Levodopa L Dopa | List of Frontiers open access articles

Review

Published on 07 Apr 2022

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence

in Neuropharmacology

Ritam Bandopadhyay
Nainshi Mishra
Ruhi Rana
Gagandeep Kaur
Mohammed M. Ghoneim
Sultan Alshehri
Gulam Mustafa
Javed Ahmad
Nabil. A. Alhakamy
Awanish Mishra

Frontiers in Pharmacology

doi 10.3389/fphar.2022.805388

21,303 views
42 citations

Original Research

Published on 03 Jan 2022

A Multiscale, Systems-Level, Neuropharmacological Model of Cortico-Basal Ganglia System for Arm Reaching Under Normal, Parkinsonian, and Levodopa Medication Conditions

Sandeep Sathyanandan Nair
Vignayanandam Ravindernath Muddapu
V. Srinivasa Chakravarthy

Frontiers in Computational Neuroscience

doi 10.3389/fncom.2021.756881

5,762 views
8 citations

Original Research

Published on 25 Jun 2021

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats

in Multiple Sclerosis and Neuroimmunology

Chang-Qing Zheng
Hong-Xia Fan
Xiao-Xian Li
Jing-Jie Li
Shuo Sheng
Feng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2021.683577

7,621 views
35 citations

Brief Research Report

Published on 29 Oct 2020

Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease

in Movement Disorders

Lanting Li
Huixia Lin
Ping Hua
Lei Yan
Hui Dong
Tan Li
Weiguo Liu

Frontiers in Neurology

doi 10.3389/fneur.2020.520934

4,245 views
13 citations

Review

Published on 04 Oct 2023

Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation

in Inflammation

Fanshi Zhang
Mei Liu
Jinmei Tuo
Li Zhang
Jun Zhang
Changyin Yu
Zucai Xu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1253273

5,996 views
15 citations

Original Research

Published on 05 Jun 2020

Pre-dopa Deep Brain Stimulation: Is Early Deep Brain Stimulation Able to Modify the Natural Course of Parkinson’s Disease?

in Neurodegeneration

Mauro Porta
Domenico Servello
Edvin Zekaj
Gabriel Gonzalez-Escamilla
Sergiu Groppa

Frontiers in Neuroscience

doi 10.3389/fnins.2020.00492

6,492 views
5 citations

Original Research

Published on 14 Jun 2019

Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa–Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson’s Rats

in Neuropharmacology

Wen-Wen Wang
Xing-Ru Zhang
Jing-Ya Lin
Zeng-Rui Zhang
Zhen Wang
Si-Yan Chen
Cheng-Long Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00660

5,054 views
9 citations

Perspective

Published on 20 Mar 2018

Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes

in Neurodegeneration

Yannick Vermeiren
Jana Janssens
Debby Van Dam
Peter P. De Deyn

Frontiers in Neuroscience

doi 10.3389/fnins.2018.00185

15,461 views
40 citations

Original Research

Published on 19 Jul 2013

Evaluation of the Objective Posturo-Locomotor-Manual Method in Patients with Parkinsonian Syndromes

in Movement Disorders

Theresa Zackrisson
Filip Bergquist
Björn Holmberg
Bo Johnels
Thorleif Thorlin

Frontiers in Neurology

doi 10.3389/fneur.2013.00095

4,276 views
6 citations

Original Research

Published on 07 Jan 2019

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice

in Parkinson’s Disease and Aging-related Movement Disorders

Eugene Huh
Jin Gyu Choi
Yeomoon Sim
Myung Sook Oh

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2018.00431

6,741 views
14 citations

Original Research

Published on 30 May 2024

IRL790 modulated striatal D1 neurons synaptic plasticity ameliorating levodopa-induced dyskinesia in mouse

in Parkinson’s Disease and Aging-related Movement Disorders

Xiaofei Wang
Wangming Zhang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1401991

2,403 views
3 citations

Original Research

Published on 12 Dec 2022

Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival

in Parkinson’s Disease and Aging-related Movement Disorders

Jun Cui
Joseph Carey
Renee A. Reijo Pera

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.1026468

3,633 views
5 citations

Case Report

Published on 18 May 2023

Case report: Bilateral double beta peak activity is influenced by stimulation, levodopa concentrations, and motor tasks, in a Parkinson’s disease patient on chronic deep brain stimulation

in Experimental Therapeutics

Giulia Giannini
Luca Baldelli
Gaetano Leogrande
Ilaria Cani
Paolo Mantovani
Giovanna Lopane
Pietro Cortelli
Giovanna Calandra-Buonaura
Alfredo Conti

Frontiers in Neurology

doi 10.3389/fneur.2023.1163811

3,205 views
9 citations

Original Research

Published on 28 Oct 2021

Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry

in Parkinson’s Disease and Aging-related Movement Disorders

Xiaoqian Zhang
Wei Chen
Yi Wu
Weiqi Zeng
Yuhao Yuan
Chi Cheng
Xiaoman Yang
Jialing Wang
Xiaomei Yang
Yu Xu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2021.759934

6,276 views
11 citations

Original Research

Published on 11 Aug 2020

Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

in Parkinson’s Disease and Aging-related Movement Disorders

Valeria Calabrese
Anna Di Maio
Gioia Marino
Antonella Cardinale
Giuseppina Natale
Arianna De Rosa
Federica Campanelli
Maria Mancini
Francesco Napolitano
Luigi Avallone

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00230

8,386 views
26 citations

Original Research

Published on 18 Oct 2017

Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Ying Wan
Na Wu
Lu Song
Xijin Wang
Zhenguo Liu
Weien Yuan
Jing Gan

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2017.00331

5,727 views
13 citations

Articles

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence

A Multiscale, Systems-Level, Neuropharmacological Model of Cortico-Basal Ganglia System for Arm Reaching Under Normal, Parkinsonian, and Levodopa Medication Conditions

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats

Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease

Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation

Pre-dopa Deep Brain Stimulation: Is Early Deep Brain Stimulation Able to Modify the Natural Course of Parkinson’s Disease?

Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa–Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson’s Rats

Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes

Evaluation of the Objective Posturo-Locomotor-Manual Method in Patients with Parkinsonian Syndromes

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice

IRL790 modulated striatal D1 neurons synaptic plasticity ameliorating levodopa-induced dyskinesia in mouse

Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival

Case report: Bilateral double beta peak activity is influenced by stimulation, levodopa concentrations, and motor tasks, in a Parkinson’s disease patient on chronic deep brain stimulation

Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry

Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease